Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States
Clinical trial NCT05329194 · COMPLETED
Trial details
- NCT number
- NCT05329194
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-29
- Primary completion
- 2025-10-01
- Enrollment
- 286
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.